tiprankstipranks
Trending News
More News >
ABIONYX Pharma SA (GB:0RAG)
LSE:0RAG
UK Market

ABIONYX Pharma SA (0RAG) Income Statement

Compare
0 Followers

ABIONYX Pharma SA Income Statement

Last quarter (Q4 2024), ABIONYX Pharma SA's total revenue was €2.26M, a decrease of -13.96% from the same quarter last year. In Q4, ABIONYX Pharma SA's net income was €-2.31M. See ABIONYX Pharma SA’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
€ 4.60M€ 4.64M€ 5.25M€ 675.00K€ 0.00
Gross Profit
€ 900.00K€ 618.00K€ 636.00K€ 259.00K€ -80.00K
Operating Expenses
€ 5.31M€ 4.03M€ 4.75M€ 6.21M€ 2.97M
Depreciation and Amortization
€ 478.00K€ 153.00K€ 135.00K€ 119.00K€ 80.00K
EBITDA
€ -4.33M€ -3.29M€ -4.01M€ -5.70M€ -2.33M
Operating Income
€ -4.50M€ -3.41M€ -4.11M€ -5.95M€ -2.97M
Other Income/Expenses
€ -967.00K€ -106.00K€ -97.00K€ 130.00K€ 1.08M
Pretax Income
€ -5.47M€ -3.52M€ -4.21M€ -5.82M€ -2.50M
Net Income
€ -4.40M€ -3.52M€ -4.21M€ -5.82M€ -1.89M
Per Share Metrics
Basic EPS
€ -0.14€ -0.12€ -0.15€ -0.23€ -0.08
Diluted EPS
€ -0.14€ -0.11€ -0.15€ -0.23€ -0.08
Weighted Average Shares Outstanding
33.70M 29.35M 27.97M 24.88M 22.51M
Weighted Average Shares Outstanding (Diluted)
33.70M 29.35M 27.97M 24.88M 22.51M
Currency in EUR

ABIONYX Pharma SA Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis